相关产品推荐更多 >

CAPS (人源) IP-WB抗体对 | CAPS (Human) IP-WB Antibody Pair
询价
GFR alpha 3 抗体-GFR alpha 3 Antibody
¥22
RP5-1022P6.2单克隆抗体 | RP5-1022P6.2 monoclonal antibody
询价
GRAM Domain Containing Protein 4 (GRAMD4) Antibody (Biotin)/GRAM Domain Containing Protein 4 (GRAMD4) Antibody (Biotin)/GRAM Domain Containing Protein 4 (GRAMD4) Antibody (Biotin)
询价
iFluor™ 670 Anti-human CD45 Antibody *HI30*/iFluor™ 670 Anti-human CD45 Antibody *HI30*/iFluor™ 670 Anti-human CD45 Antibody *HI30*
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
Mus musculus / MS4A1 [Homo sapiens]
- 保存条件:
Store at -80℃
- 保质期:
1年
- 级别:
科研级别
- 库存:
100
- 供应商:
艾美捷科技
- 抗体英文名:
Ibritumomab Tiuxetan (MS4A1) Antibody, Monoclonal
- 抗体名:
Ibritumomab Tiuxetan (MS4A1) Antibody, Monoclonal
- 规格:
0.1mg
Ibritumomab Tiuxetan (MS4A1) 抗体, 单克隆,Ibritumomab Tiuxetan (MS4A1) Antibody, Monoclonal,Ibritumomab Tiuxetan (MS4A1) 抗体, 单克隆,Ibritumomab Tiuxetan (MS4A1) Antibody, Monoclonal
产品名称:Ibritumomab Tiuxetan (MS4A1) 抗体, 单克隆-Ibritumomab Tiuxetan (MS4A1) Antibody, Monoclonal
产品货号:PSI-10-146-0.1mg
产品规格:0.1mg
背景资料:Indium or yttrium conjugated murine IgG1 kappa monoclonal antibody directed against the CD20 antigen,which is found on the surface of normal and malignant B lymphocytes.Ibritumomab is produced in Chinese hamster ovary cells and is composed of two murine gamma 1 heavy chains of 445 amino acids each and two kappa light chains of 213 amino acids each.The Fab segment of the antibody targets the CD20 epitope on B-cells,allowing the radioactive yttrium to destroy the cell via production of beta particles.
保存建议:Ibritumomab Tiuxetan (MS4A1) 抗体, 单克隆-Ibritumomab Tiuxetan (MS4A1) Antibody, MonoclonalStore at -80℃
应用类型:
点击:Ibritumomab Tiuxetan (MS4A1) 抗体, 单克隆-Ibritumomab Tiuxetan (MS4A1) Antibody, Monoclonal查看更详细产品说明,更多应用、储存、价格、货期等信息请垂询艾美捷科技有限公司。更多ProSci公司特色试剂盒、特色抗体以及特色试剂等产品评论,请点击查看艾美捷特色产品中心。
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验【翻译】Development trends for monoclonal antibody cancer therapeutics
two murine, Y-90 ibritumomab tiuxetan (Zevalin; Biogen Idec) and I-131 tositumomab (Bexxar; Corixa/GSK), and one chimeric, I-131 ch-TNT (Shanghai Medipharm Biotech) — have been approved for non-Hodgkin's lymphoma or lung cancer, but only 14% of anticancer
技术资料暂无技术资料 索取技术资料







